Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis

Jingqi Zhang1, Jing Wu1, Xiaohua Sun2

  • 1Department of Epidemiology and Statistics, School of Public Health, Jiangsu Key Laboratory and Translational Medicine for Geriatric Disease, Medical College of Soochow University, Soochow, China.

Insights

Hypertension significantly increases the risk of severe COVID-19 illness and death. This meta-analysis confirms that individuals with high blood pressure face a higher likelihood of critical outcomes from SARS-CoV-2 infection.

Area of Science:

  • Infectious Diseases
  • Cardiovascular Medicine
  • Public Health

Background:

  • Hypertension is a prevalent comorbidity among patients diagnosed with COVID-19.
  • The precise relationship between hypertension and the severity or fatality of SARS-CoV-2 infection requires further clarification.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the impact of hypertension on COVID-19 severity and fatality.
  • To synthesize evidence from published studies to quantify the risks associated with hypertension in COVID-19 patients.

Main Methods:

  • A systematic literature search was performed across multiple databases (PubMed, Elsevier, Web of Science, Wiley, Embase, CNKI) up to March 20, 2020.
  • Meta-analysis included 12 publications for severity (2389 patients) and six studies for fatality (2116 patients).
  • Pooled odds ratios (ORs) and confidence intervals (CIs) were calculated to assess the association between hypertension and COVID-19 outcomes.

Main Results:

  • Hypertensive COVID-19 patients exhibited a significantly higher severity rate (37.58%) compared to non-hypertensive patients (19.73%; pooled OR: 2.27).
  • Hypertension increased the risk of COVID-19 fatality by approximately 3.48-fold (95% CI: 1.72-7.08).
  • Increased risks for severity and fatality were observed across different age groups (<50 and ⩾50 years).

Conclusions:

  • Hypertension is a significant risk factor for both increased severity and higher fatality rates in SARS-CoV-2 infection.
  • The findings underscore the importance of managing hypertension in the context of COVID-19.
  • No significant heterogeneity or publication bias was detected, strengthening the study's conclusions.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
607
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
362
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
778
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
560
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
577
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K